[Corrigendum] PF‑2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells
- Authors:
- Published online on: January 24, 2024 https://doi.org/10.3892/etm.2024.12399
- Article Number: 111
-
Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article
Exp Ther Med 15:[Related article:] 4543–4549, 2018; DOI: 10.3892/etm.2018.5967
Subsequently to the publication of the above article, the authors drew to the Editor’s attention that the western blots shown in Fig. 2H and I had been represented using the same control western blots, whereas these figure parts should have been shown incorporated in the same figure panel (now Fig. 2H; see the revised figure opposite). Moreover, the second-listed author (Dinghua Yang) requested that their name be removed from the article, with the agreement of all the other authors. Consequently, the corresponding author on this paper is now the first-named author, Chen Chen. The revised author affiliation details are therefore as follows:
CHEN CHEN1, QINGHUA ZENG2, LIANG LUO1 and CHENGZHI CAI1
1Department of Hepatobiliary Surgery; 2Department of Rheumatology and Immunology, Hunan Provincial People’s Hospital, Changsha, Hunan 410002, P.R. China
Correspondence to: Dr Chen Chen, Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital, 61 Jiefang West Road, Changsha, Hunan 410002, P.R. China E-mail: chenchen2043@163.com
Note that the error associated with the assembly of Fig. 2 did not have a major impact on either the overall results or on the conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Experimental and Therapeutic Medicine for granting them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused.